Seresto

Verify with FDA CVM →

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
1
Deaths Reported
670.0%
Death Rate

Active Ingredients

Seresto

Administration Routes

TopicalUnknown

Species Affected

Dog 12
Cat 3

Most Affected Breeds

Retriever - Labrador 3
Terrier - Bull - American Pit 2
Domestic Shorthair 2
Retriever - Golden 2
Shepherd Dog - Australian 1
Shepherd Dog - German 1
Siberian Husky 1
Domestic Longhair 1
Shepherd Dog - Belgian Malinois 1
Terrier - Bull 1

Most Reported Reactions

Lack of efficacy (bacteria) - Borrelia 5
Lack of efficacy (ectoparasite) - tick NOS 2
Vomiting 2
Lack of efficacy (ectoparasite) - flea 2
Facial swelling (see also 'Skin') 1
Pruritus 1
Localised hair loss 1
INEFFECTIVE, ANTIINFLAMMATORY 1
Erosion 1
Dermatitis 1
Lack of efficacy - NOS 1
Haemorrhagic gastroenteritis 1

Outcome Breakdown

Ongoing
12 (80.0%)
Recovered/Normal
1 (6.7%)
Outcome Unknown
1 (6.7%)
Euthanized
1 (6.7%)

Data Summary

Metric Value
Total adverse event reports 15
Reports involving death 1
Case-fatality rate (reported events) 670.0%
Distinct species in reports 2
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Seresto Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 15 adverse event reports referencing Seresto, including 1 reports in which the animal died — a 670.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Seresto. Reported administration routes include Topical, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Seresto reports are Dog (12 reports), Cat (3 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), Terrier - Bull - American Pit (2), Domestic Shorthair (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Seresto are Lack of efficacy (bacteria) - Borrelia (5), Lack of efficacy (ectoparasite) - tick NOS (2), Vomiting (2), Lack of efficacy (ectoparasite) - flea (2). Of the 15 reports with a coded outcome, Ongoing is the leading category at 80.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Seresto.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial